SCHEMBL2754993

SCHEMBL2754993

CNC(=O)CCSSCC(NC(C)=O)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.56
▸ MAPT P10636 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ PTGS2 P35354 1/20 0.43
▸ THPO P40225 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ ITGB1 P05556 3/20 0.37
▸ ITGA4 P13612 3/20 0.37
▸ FOLH1 Q04609 3/20 0.36
▸ RIMKLA Q8IXN7 1/20 0.36
▸ NAALAD2 Q9Y3Q0 1/20 0.36
▸ GNPAT O15228 1/20 0.35
▸ MMP2 P08253 1/20 0.35
▸ MMP9 P14780 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24067699 0.83 MAPT (0.59) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL308082 0.83 MAPT (0.59) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL308083 0.83 MAPT (0.59) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL25329304 0.83 MAPT (0.59) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL2140974 0.83 MAPT (0.59) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL12997194 0.83 MAPT (0.44) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL24378366 0.82 MAPT (0.50) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL25340359 0.81 MAPT (0.57) MAPTKDM4ETHRBALOX15NFKB1
SCHEMBL31253447 0.81 MAPT (0.57) MAPTKDM4ETHRBALOX15NFKB1
Water SCHEMBL8124987 0.81 MAPT (0.57) MAPTKDM4ETHRBALOX15NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150141350-A1 DENDRIMER BASED NANODEVICES FOR THERAPEUTIC AND IMAGING PURPOSES Ashvattha Therapeutics, Inc. 2015-05-21 — — US disclosed
US-8889101-B2 Dendrimer based nanodevices for therapeutic and imaging purposes WAYNE STATE UNIVERSITY (US) 2014-11-18 — — US disclosed
US-20120003155-A1 DENDRIMER BASED NANODEVICES FOR THERAPEUTIC AND IMAGING PURPOSES NATIONAL INSTITUTES OF HEALTH (US) 2012-01-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150141350-A1 DENDRIMER BASED NANODEVICES FOR THERAPEUTIC AND IMAGING PURPOSES PAM, MUC1, AADAC LMNA 2887/4885MAPT 904/4885KDM4E 4773/4885
US-20120003155-A1 DENDRIMER BASED NANODEVICES FOR THERAPEUTIC AND IMAGING PURPOSES PAM, MUC1, AADAC LMNA 2887/4885MAPT 904/4885KDM4E 4773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback